Norgestimate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Norgestimate
Canada

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2026-04-20

PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

Contact Supplier

Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Contact Supplier

pharmacompass-2-m-2026-04-20

Norgestimate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 9 USDMF, 6 CEP/COS, 4 NDC API, 7 Listed Suppliers

17 API Suppliers
9 USDMF
6 CEP/COS
4 NDC API
7 Listed Suppliers

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

71 FDF Dossiers, 40 FDA Orange Book, 10 Europe, 18 Canada, 3 South Africa

71 FDF Dossiers
40 FDA Orange Book
10 Europe
18 Canada
3 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 Others

2 EDQM
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

18 All

01 12APOTEX INC

02 6GLENMARK PHARMACEUTICALS CANADA INC.

filter Active Ingredients Reset all filters

18 All

01 18NORGESTIMATE

filter Dosage Form Reset all filters

18 All

01 18TABLET

filter Brand Name Reset all filters

18 All

01 3TRI-CIRA 21

02 3TRI-CIRA 28

03 3TRI-CIRA LO 21

04 3TRI-CIRA LO 28

05 3TRI-JORDYNA 21

06 3TRI-JORDYNA 28

List of Suppliers

Product Main Page

01

APOTEX INC

Bioprocess International Europe

Not Confirmed

APOTEX INC

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

PCC

Not Confirmed

APOTEX INC

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

PCC

Not Confirmed

APOTEX INC

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX INC

PCC

Not Confirmed

APOTEX INC

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

APOTEX INC

PCC

Not Confirmed

APOTEX INC

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

APOTEX INC

PCC

Not Confirmed

APOTEX INC

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

APOTEX INC

Bioprocess International Europe

Not Confirmed

APOTEX INC

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

APOTEX INC

Bioprocess International Europe

Not Confirmed

APOTEX INC

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

APOTEX INC

Bioprocess International Europe

Not Confirmed

APOTEX INC

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

APOTEX INC

Bioprocess International Europe

Not Confirmed

APOTEX INC

Bioprocess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NORGESTIMATE

Brand Name : TRI-CIRA 28

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 2508095

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.